Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review.

Related Articles

Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review.

PLoS One. 2017;12(4):e0175538

Authors: Navas-Madroñal M, Valero-Mut A, Martínez-Zapata MJ, Simón-Talero MJ, Figueroa S, Vidal-Fernández N, López-Góngora M, Escartín A, Querol L

Abstract
INTRODUCTION: Antibodies targeting the inward-rectifying potassium channel KIR4.1 have been associated with multiple sclerosis (MS) but studies using diverse techniques have failed to replicate this association. The detection of these antibodies is challenging; KIR4.1 glycosylation patterns and the use of diverse technical approaches may account for the disparity of results. We aimed to replicate the association using three different approaches to overcome the technical limitations of a single technique. We also performed a systematic review to examine the association of anti-KIR4.1 antibodies with MS.
METHODS: Serum samples from patients with MS (n = 108) and controls (n = 77) were tested for the presence of anti-KIR4.1 antibodies using three methods: 1) by ELISA with the low-glycosylated fraction of recombinant KIR4.1 purified from transfected HEK293 cells according to original protocols; 2) by immunocytochemistry using KIR4.1-transfected HEK293 cells; and 3) by immunocytochemistry using the KIR4.1.-transfected MO3.13 oligodendrocyte cell line. We developed a systematic review and meta-analysis of the association of anti-KIR4.1 antibodies with MS according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
RESULTS: We did not detect anti-KIR4.1 antibodies in the MS patients or in controls using ELISA. Neither did we detect any significant reactivity against the antigen on the cell surface using the KIR4.1-transfected HEK293 cells or the KIR4.1-transfected MO3.13 cells. We included 13 prospective controlled studies in the systematic review. Only three studies showed a positive association between anti-KIR4.1 and MS. Clinical and statistical heterogeneity between studies precluded meta-analysis of their results.
CONCLUSION: We found no association between anti-KIR4.1 antibody positivity and MS. Although this lack of replication may be due to technical limitations, evidence from our study and others is mounting against the role of KIR4.1 as a relevant MS autoantigen.

PMID: 28414733 [PubMed - in process]

Pablo

Que yá nun podemos tar

oyendo la mesma agua

del rullar de cada dí­a:

vásenos ensin palabra,

tuya y mía, cada instante

como páxaru qu’esnala

ensin un cantar d’azul

nomeolvides, ensin nada.
Yes pa mios oyos tan tuyos

amante llume llonxana:

fueu de besar perselino

y señardá que me llama.
Que seya un netu gociar

los sabores de mazana…

Que l’amor de l’alta nueche

tien la más dulce alborada.
Que yá nun podemos tar,

yá que puede la distancia

más que los suaños de dos

suañando la mesma agua
Yes pa mios oyos tan tuyos

amante llume llonxana:

fueu de besar perselino

y señardá que me llama.